{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:29:58Z","timestamp":1789784998096,"version":"4.0.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,10,24]],"date-time":"2013-10-24T00:00:00Z","timestamp":1382572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"},{"start":{"date-parts":[[2013,10,24]],"date-time":"2013-10-24T00:00:00Z","timestamp":1382572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/srep03042","type":"journal-article","created":{"date-parts":[[2013,10,24]],"date-time":"2013-10-24T09:02:42Z","timestamp":1382605362000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["JAK1 truncating mutations in gynecologic cancer define new role of cancer-associated protein tyrosine kinase aberrations"],"prefix":"10.1038","volume":"3","author":[{"given":"Yuan","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard Z.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Fenstermacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth L.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie K.","family":"Teer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,24]]},"reference":[{"key":"BFsrep03042_CR1","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S1470-2045(10)70087-5","volume":"12","author":"W Pao","year":"2011","unstructured":"Pao, W. & Girard, N. New driver mutations in non-small-cell lung cancer. Lancet Oncol 12, 175\u201380 (2011).","journal-title":"Lancet Oncol"},{"key":"BFsrep03042_CR2","doi-asserted-by":"crossref","unstructured":"Gilliland, D. G., Jordan, C. T. & Felix, C. A. The molecular basis of leukemia. Hematology (Am Soc Hematol Educ Program), 80\u201397 (2004).","DOI":"10.1182\/asheducation-2004.1.80"},{"key":"BFsrep03042_CR3","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1182\/blood-2004-08-3097","volume":"105","author":"M Deininger","year":"2005","unstructured":"Deininger, M., Buchdunger, E. & Druker, B. J. The development of imatinib as a therapeutic agent for chronic myeloid leukemia. Blood 105, 2640\u201353 (2005).","journal-title":"Blood"},{"key":"BFsrep03042_CR4","doi-asserted-by":"publisher","first-page":"550","DOI":"10.4161\/cc.6.5.3919","volume":"6","author":"A Tefferi","year":"2007","unstructured":"Tefferi, A. & Gilliland, D. G. Oncogenes in myeloproliferative disorders. Cell Cycle 6, 550\u201366 (2007).","journal-title":"Cell Cycle"},{"key":"BFsrep03042_CR5","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1177\/1947601910397187","volume":"1","author":"SS Jatiani","year":"2010","unstructured":"Jatiani, S. S., Baker, S. J., Silverman, L. R. & Reddy, E. P. Jak\/STAT pathways in cytokine signaling and myeloproliferative disorders: approaches for targeted therapies. Genes Cancer 1, 979\u201393 (2010).","journal-title":"Genes Cancer"},{"key":"BFsrep03042_CR6","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.1182\/blood-2011-11-395228","volume":"119","author":"A Tefferi","year":"2012","unstructured":"Tefferi, A. JAK inhibitors for myeloproliferative neoplasms: clarifying facts from myths. Blood 119, 2721\u201330 (2012).","journal-title":"Blood"},{"key":"BFsrep03042_CR7","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1042\/BJ20100774","volume":"432","author":"GM Gordon","year":"2010","unstructured":"Gordon, G. M., Lambert, Q. T., Daniel, K. G. & Reuther, G. W. Transforming JAK1 mutations exhibit differential signalling, FERM domain requirements and growth responses to interferon-gamma. Biochem J 432, 255\u201365 (2010).","journal-title":"Biochem J"},{"key":"BFsrep03042_CR8","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0065-230X(08)00407-7","volume":"101","author":"B Seliger","year":"2008","unstructured":"Seliger, B., Ruiz-Cabello, F. & Garrido, F. IFN inducibility of major histocompatibility antigens in tumors. Adv Cancer Res 101, 249\u201376 (2008).","journal-title":"Adv Cancer Res"},{"key":"BFsrep03042_CR9","first-page":"2487","volume":"9","author":"L Wall","year":"2003","unstructured":"Wall, L., Burke, F., Barton, C., Smyth, J. & Balkwill, F. IFN-gamma induces apoptosis in ovarian cancer cells in vivo and in vitro. Clin Cancer Res 9, 2487\u201396 (2003).","journal-title":"Clin Cancer Res"},{"key":"BFsrep03042_CR10","doi-asserted-by":"publisher","first-page":"7556","DOI":"10.1073\/pnas.95.13.7556","volume":"95","author":"DH Kaplan","year":"1998","unstructured":"Kaplan, D. H. et al. Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci U S A 95, 7556\u201361 (1998).","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFsrep03042_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1189\/jlb.0603252","volume":"75","author":"K Schroder","year":"2004","unstructured":"Schroder, K., Hertzog, P. J., Ravasi, T. & Hume, D. A. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75, 163\u201389 (2004).","journal-title":"J Leukoc Biol"},{"key":"BFsrep03042_CR12","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1084\/jem.181.4.1459","volume":"181","author":"KL Wright","year":"1995","unstructured":"Wright, K. L. et al. Coordinate regulation of the human TAP1 and LMP2 genes from a shared bidirectional promoter. J Exp Med 181, 1459\u201371 (1995).","journal-title":"J Exp Med"},{"key":"BFsrep03042_CR13","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/365264a0","volume":"365","author":"M Gaczynska","year":"1993","unstructured":"Gaczynska, M., Rock, K. L. & Goldberg, A. L. Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature 365, 264\u20137 (1993).","journal-title":"Nature"},{"key":"BFsrep03042_CR14","first-page":"24","volume":"62","author":"T Hayashi","year":"2002","unstructured":"Hayashi, T. & Faustman, D. L. Development of spontaneous uterine tumors in low molecular mass polypeptide-2 knockout mice. Cancer Res 62, 24\u20137 (2002).","journal-title":"Cancer Res"},{"key":"BFsrep03042_CR15","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/srep00180","volume":"1","author":"T Hayashi","year":"2011","unstructured":"Hayashi, T. et al. Potential role of LMP2 as tumor-suppressor defines new targets for uterine leiomyosarcoma therapy. Sci Rep 1, 180 (2011).","journal-title":"Sci Rep"},{"key":"BFsrep03042_CR16","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1097\/PPO.0b013e318238216e","volume":"17","author":"DA Fenstermacher","year":"2011","unstructured":"Fenstermacher, D. A., Wenham, R. M., Rollison, D. E. & Dalton, W. S. Implementing personalized medicine in a cancer center. Cancer J 17, 528\u201336 (2011).","journal-title":"Cancer J"},{"key":"BFsrep03042_CR17","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nature11003","volume":"483","author":"J Barretina","year":"2012","unstructured":"Barretina, J. et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483, 603\u20137 (2012).","journal-title":"Nature"},{"key":"BFsrep03042_CR18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nrc1275","volume":"4","author":"H Yu","year":"2004","unstructured":"Yu, H. & Jove, R. The STATs of cancer--new molecular targets come of age. Nat Rev Cancer 4, 97\u2013105 (2004).","journal-title":"Nat Rev Cancer"},{"key":"BFsrep03042_CR19","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1126\/science.7517574","volume":"265","author":"H de la Salle","year":"1994","unstructured":"de la Salle, H. et al. Homozygous human TAP peptide transporter mutation in HLA class I deficiency. Science 265, 237\u201341 (1994).","journal-title":"Science"},{"key":"BFsrep03042_CR20","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/S0092-8674(05)80068-6","volume":"71","author":"L Van Kaer","year":"1992","unstructured":"Van Kaer, L., Ashton-Rickardt, P. G., Ploegh, H. L. & Tonegawa, S. TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4-8+ T cells. Cell 71, 1205\u201314 (1992).","journal-title":"Cell"},{"key":"BFsrep03042_CR21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nature12113","volume":"497","author":"C Kandoth","year":"2013","unstructured":"Kandoth, C. et al. Integrated genomic characterization of endometrial carcinoma. Nature 497, 67\u201373 (2013).","journal-title":"Nature"},{"key":"BFsrep03042_CR22","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754\u201360 (2009).","journal-title":"Bioinformatics"},{"key":"BFsrep03042_CR23","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/ng.806","volume":"43","author":"MA DePristo","year":"2011","unstructured":"DePristo, M. A. et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 43, 491\u20138 (2011).","journal-title":"Nat Genet"},{"key":"BFsrep03042_CR24","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang, K., Li, M. & Hakonarson, H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 38, e164 (2010).","journal-title":"Nucleic Acids Res"},{"key":"BFsrep03042_CR25","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1101\/gr.111120.110","volume":"21","author":"G Lunter","year":"2011","unstructured":"Lunter, G. & Goodson, M. Stampy: a statistical algorithm for sensitive and fast mapping of Illumina sequence reads. Genome Res 21, 936\u20139 (2011).","journal-title":"Genome Res"},{"key":"BFsrep03042_CR26","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The Sequence Alignment\/Map format and SAMtools. Bioinformatics 25, 2078\u20139 (2009).","journal-title":"Bioinformatics"},{"key":"BFsrep03042_CR27","doi-asserted-by":"publisher","first-page":"14468","DOI":"10.1074\/jbc.273.23.14468","volume":"273","author":"JM Cunnick","year":"1998","unstructured":"Cunnick, J. M. et al. Role of tyrosine kinase activity of epidermal growth factor receptor in the lysophosphatidic acid-stimulated mitogen-activated protein kinase pathway. J Biol Chem 273, 14468\u201375 (1998).","journal-title":"J Biol Chem"},{"key":"BFsrep03042_CR28","doi-asserted-by":"publisher","first-page":"34970","DOI":"10.1074\/jbc.M112.374611","volume":"287","author":"CX Xu","year":"2012","unstructured":"Xu, C. X. et al. MicroRNA miR-214 regulates ovarian cancer cell stemness by targeting p53\/Nanog. J Biol Chem 287, 34970\u20138 (2012).","journal-title":"J Biol Chem"},{"key":"BFsrep03042_CR29","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1177\/1947601910395582","volume":"1","author":"Y Ren","year":"2010","unstructured":"Ren, Y. et al. Critical role of Shp2 in tumor growth involving regulation of c-Myc. Genes Cancer 1, 994\u20131007 (2010).","journal-title":"Genes Cancer"},{"key":"BFsrep03042_CR30","doi-asserted-by":"publisher","first-page":"36463","DOI":"10.1074\/jbc.M705789200","volume":"282","author":"Y Ren","year":"2007","unstructured":"Ren, Y. et al. Shp2E76K mutant confers cytokine-independent survival of TF-1 myeloid cells by up-regulating Bcl-XL. J Biol Chem 282, 36463\u201373 (2007).","journal-title":"J Biol Chem"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep03042.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep03042","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep03042.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T05:06:16Z","timestamp":1672981576000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep03042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,24]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,11,13]]}},"alternative-id":["BFsrep03042"],"URL":"https:\/\/doi.org\/10.1038\/srep03042","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,24]]},"assertion":[{"value":"22 May 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3042"}}